(NASDAQ: EDSA) Edesa Biotech's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 9.64%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.81%.
Edesa Biotech's earnings in 2025 is -$5,837,964.On average, 2 Wall Street analysts forecast EDSA's earnings for 2025 to be -$8,637,894, with the lowest EDSA earnings forecast at -$9,059,255, and the highest EDSA earnings forecast at -$8,216,533. On average, 2 Wall Street analysts forecast EDSA's earnings for 2026 to be -$6,811,998, with the lowest EDSA earnings forecast at -$9,691,296, and the highest EDSA earnings forecast at -$3,932,700.
In 2027, EDSA is forecast to generate -$3,160,205 in earnings, with the lowest earnings forecast at -$3,160,205 and the highest earnings forecast at -$3,160,205.